Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elevation in inflammatory serum biomarkers predicts response to trastuzumab-containing therapy.

Alkhateeb AA, Leitzel K, Ali SM, Campbell-Baird C, Evans M, Fuchs EM, Köstler WJ, Lipton A, Connor J. Elevation in inflammatory serum biomarkers predicts response to trastuzumab-containing therapy. PLoS One. 2012; 7(12):e51379.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.